Header

UZH-Logo

Maintenance Infos

Questions regarding the optimal use of bevacizumab in glioblastoma: a moving target


Stupp, R; Weller, M (2014). Questions regarding the optimal use of bevacizumab in glioblastoma: a moving target. Neuro-Oncology, 16(6):765-767.

Statistics

Citations

7 citations in Web of Science®
8 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

106 downloads since deposited on 20 Aug 2014
22 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology
04 Faculty of Medicine > University Hospital Zurich > Clinic for Oncology
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:June 2014
Deposited On:20 Aug 2014 12:59
Last Modified:06 Aug 2017 23:13
Publisher:Oxford University Press
ISSN:1522-8517
Additional Information:This is a pre-copyedited, author-produced PDF of an article accepted for publication in Neuro-Oncology following peer review. The definitive publisher-authenticated version Questions regarding the optimal use of bevacizumab in glioblastoma: a moving target is available online at: http://neuro-oncology.oxfordjournals.org/content/16/6/765
Free access at:PubMed ID. An embargo period may apply.
Publisher DOI:https://doi.org/10.1093/neuonc/nou092
PubMed ID:24826844

Download

Download PDF  'Questions regarding the optimal use of bevacizumab in glioblastoma: a moving target'.
Preview
Content: Accepted Version
Filetype: PDF
Size: 125kB
View at publisher
Download PDF  'Questions regarding the optimal use of bevacizumab in glioblastoma: a moving target'.
Preview
Content: Published Version
Filetype: PDF
Size: 76kB